跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 44 条关于
“veligrotug-vvze”
全部
44
临床试验
18
药物
14
机构
0
资讯
12
前天
Sling Therapeutics Doses First Patients in Phase III ORBIT Trial of Oral Linsitinib for Thyroid Eye Disease
2年前
Veligrotug Shows Positive Phase 3 Results for Thyroid Eye Disease
去年
Viridian's Veligrotug Shows Promise in Phase 3 Trial for Chronic Thyroid Eye Disease
2年前
Viridian Therapeutics' Veligrotug Achieves Positive Phase III Results in Thyroid Eye Disease
9个月前
FDA Grants Priority Review to Viridian Therapeutics' Veligrotug for Thyroid Eye Disease
2年前
Viridian Therapeutics' Veligrotug Shows Promise in Phase III Thyroid Eye Disease Trial
去年
Viridian Therapeutics Secures $385 Million Deal with Kissei for Thyroid Eye Disease Therapies in Japan
11个月前
Viridian Therapeutics Secures $300M Royalty Financing to Advance Thyroid Eye Disease Therapies
去年
TEPEZZA Sales Surge as Thyroid Eye Disease Treatment Market Expands to $2.3 Billion
去年
Promising Phase 1/2 Results for ACELYRIN's Lonigutamab Support Buy Rating
第 1 页,共 2 页
上一页
下一页